Your browser doesn't support javascript.
loading
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
Benson, Constance A; Andersen, Janet W; Macatangay, Bernard J C; Mailliard, Robbie B; Rinaldo, Charles R; Read, Sarah; Bozzolo, Dawn R; Purdue, Lynette; Jennings, Cheryl; Keefer, Michael C; Glesby, Marshall; Tebas, Pablo; Russell, Amy Falk; Martin, Jason; Annunziato, Paula; Popmihajlov, Zoran; Lennox, Jeffrey L.
Afiliación
  • Benson CA; Division of Infectious Diseases, University of California, San Diego.
  • Andersen JW; Statistical and Data Analysis Center, Harvard School of Public Health, Boston, Massachusetts.
  • Macatangay BJC; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pennsylvania.
  • Mailliard RB; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pennsylvania.
  • Rinaldo CR; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pennsylvania.
  • Read S; Therapeutics Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville.
  • Bozzolo DR; Social and Scientific Systems, Inc, Silver Spring.
  • Purdue L; Pharmaceutical Affairs Branch, Division of AIDS, NIAID/NIH, Rockville, Maryland.
  • Jennings C; Clinical Retrovirology Research Laboratory, Rush University, Chicago, Illinois.
  • Keefer MC; Division of Infectious Diseases, University of Rochester, New York, New York.
  • Glesby M; Division of Infectious Diseases, Weill Cornell Medical College, Cornell University, New York, New York.
  • Tebas P; Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Russell AF; Clinical Research, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey.
  • Martin J; Biostatistics and Research Decision Sciences, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey.
  • Annunziato P; Clinical Research, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey.
  • Popmihajlov Z; Clinical Research, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey.
  • Lennox JL; Division of Infectious Diseases, Emory University, Atlanta, Georgia.
Clin Infect Dis ; 67(11): 1712-1719, 2018 11 13.
Article en En | MEDLINE | ID: mdl-29590326
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Terapia Antirretroviral Altamente Activa / Vacuna contra el Herpes Zóster / Respuesta Virológica Sostenida / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Terapia Antirretroviral Altamente Activa / Vacuna contra el Herpes Zóster / Respuesta Virológica Sostenida / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos